• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强磁共振成像在肝胆小管细胞癌中的应用:影像学特征与组织病理学相关性。

Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.

机构信息

Department of Radiology, Nihon University School of Medicine, 30-1, Ohyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan.

Department of Radiology, Showa General Hospital, Koganei, Japan.

出版信息

Eur Radiol. 2017 Nov;27(11):4461-4471. doi: 10.1007/s00330-017-4811-2. Epub 2017 Apr 24.

DOI:10.1007/s00330-017-4811-2
PMID:28439650
Abstract

OBJECTIVES

To review the gadoxetic acid disodium (EOB)-enhanced magnetic resonance (MR) imaging features of cholangiolocellular carcinoma (CoCC) of the liver and compare them with those of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).

METHODS

EOB-enhanced MR images of 19 patients with CoCC, 23 with ICC, and 51 with HCC were retrospectively evaluated qualitatively and quantitatively. Univariate and multivariate analyses were performed to determine the characteristic MR features of CoCC with histopathological-imaging correlation.

RESULTS

Multivariate logistic regression analysis showed that dot-/band-shaped internal enhancement during the arterial and portal phases (P < 0.001), and larger arterial ring enhancement ratio (CoCC, 0.13 ± 0.04; ICC, 0.074 ± 0.04; P = 0.013) were significantly independently associated with CoCC in contrast to ICC, whereas several MR features including progressive enhancement during the portal and late phases (P < 0.001), target appearance in the hepatocyte phase (P = 0.004), and vessel penetration (P = 0.013) were significantly more frequently associated with CoCC than HCC. The dot-/band-like internal enhancement (78.9% of CoCCs) histopathologically corresponded to the tumour cell nest with vascular proliferations and retained Glisson's sheath structure.

CONCLUSIONS

EOB-enhanced MR features of CoCC largely differ from those of HCC but are similar to those of ICC. However, the finding of thicker arterial ring enhancement with dot-/band-like internal enhancement could help differentiate CoCC from ICC.

KEY POINTS

• Gadoxetic acid-enhanced MR features of cholangiolocellular carcinoma (CoCC) resembled those of intrahepatic cholangiocarcinoma (ICC). • Gadoxetic acid-enhanced MR features of CoCC largely differed from those of hepatocellular carcinoma. • Dot-/band-like internal enhancement of CoCC may be helpful for differentiating from ICC. • Arterial ring enhancement of CoCC was larger than that of ICC.

摘要

目的

回顾钆塞酸二钠(EOB)增强磁共振(MR)成像在肝内胆小管细胞癌(CoCC)中的表现,并与肝细胞癌(HCC)和肝内胆管细胞癌(ICC)进行比较。

方法

回顾性分析 19 例 CoCC、23 例 ICC 和 51 例 HCC 的 EOB 增强 MR 图像,进行定性和定量分析。通过单变量和多变量分析,结合组织病理学和影像学进行相关性分析,确定 CoCC 的特征性 MR 表现。

结果

多变量逻辑回归分析显示,动脉期和门静脉期的点状/条带状内部强化(P < 0.001)和较大的动脉环强化比值(CoCC,0.13 ± 0.04;ICC,0.074 ± 0.04;P = 0.013)与 ICC 相比,与 CoCC 显著相关,而一些 MR 特征,包括门静脉期和延迟期的渐进性强化(P < 0.001)、肝细胞期的靶征(P = 0.004)和血管穿透(P = 0.013)与 CoCC 相比,更常见于 CoCC 而不是 HCC。点状/条带状内部强化(78.9%的 CoCC)与具有血管增生和保留 Glisson 鞘结构的肿瘤细胞巢在组织病理学上相对应。

结论

EOB 增强 MR 特征在很大程度上不同于 HCC,但与 ICC 相似。然而,发现较厚的动脉环强化与点状/条带状内部强化有助于将 CoCC 与 ICC 区分开来。

关键要点

  • 胆内胆小管细胞癌(CoCC)的钆塞酸二钠增强磁共振(MR)特征与肝内胆管细胞癌(ICC)相似。

  • CoCC 的 EOB 增强 MR 特征与肝细胞癌(HCC)有很大的不同。

  • CoCC 的点状/条带状内部强化可能有助于与 ICC 区分。

  • CoCC 的动脉环强化大于 ICC。

相似文献

1
Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.钆塞酸二钠增强磁共振成像在肝胆小管细胞癌中的应用:影像学特征与组织病理学相关性。
Eur Radiol. 2017 Nov;27(11):4461-4471. doi: 10.1007/s00330-017-4811-2. Epub 2017 Apr 24.
2
Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.钆塞酸二钠增强肝脏磁共振成像上肝内肿块型胆管癌与肝细胞癌的鉴别诊断
Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.
3
Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.肝硬化患者肝内胆管细胞癌:钆塞酸增强磁共振成像和动态 CT 鉴别诊断肝细胞癌。
Radiology. 2017 Mar;282(3):771-781. doi: 10.1148/radiol.2016160639. Epub 2016 Oct 31.
4
Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.辅助成像特征在钆塞酸增强磁共振成像上鉴别硬化型肝细胞癌与肝内胆管细胞癌的价值。
Eur Radiol. 2018 Jun;28(6):2549-2560. doi: 10.1007/s00330-017-5196-y. Epub 2018 Jan 15.
5
Differentiation between inflammatory myofibroblastic tumor and cholangiocarcinoma manifesting as target appearance on gadoxetic acid-enhanced MRI.在钆塞酸增强 MRI 上表现为靶征的炎性肌纤维母细胞瘤与胆管细胞癌的鉴别诊断。
Abdom Radiol (NY). 2019 Apr;44(4):1395-1406. doi: 10.1007/s00261-018-1847-y.
6
Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.钆塞酸二钠增强 MRI 成像对肝内胆管细胞癌的影像学特征。
Eur J Radiol. 2013 Mar;82(3):e101-6. doi: 10.1016/j.ejrad.2012.10.010. Epub 2012 Nov 16.
7
Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.使用钆塞酸增强 MRI 鉴别混合细胞型肝癌和巨块型肝内胆管细胞癌。
J Magn Reson Imaging. 2012 Oct;36(4):881-9. doi: 10.1002/jmri.23728. Epub 2012 Jun 21.
8
Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.对比增强超声对时间特征的详细分析可能有助于鉴别肝硬化患者肝内胆管癌与肝细胞癌。
PLoS One. 2014 May 29;9(5):e98612. doi: 10.1371/journal.pone.0098612. eCollection 2014.
9
MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.MRI 特征可预测肝内胆管细胞癌中的微血管侵犯。
Cancer Imaging. 2020 Jun 23;20(1):40. doi: 10.1186/s40644-020-00318-x.
10
Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.CT 和钆塞酸增强磁共振成像上肝肉瘤样癌的影像学特征。
Abdom Radiol (NY). 2017 May;42(5):1424-1433. doi: 10.1007/s00261-016-1038-7.

引用本文的文献

1
Beyond cholangiocarcinoma: imaging features of mimicking pathologies in the biliary tract.胆管癌之外:胆道模拟病变的影像学特征
Abdom Radiol (NY). 2024 Dec 23. doi: 10.1007/s00261-024-04749-z.
2
A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.基于磁共振成像特征的一种用于鉴别肝内肿块型胆管细胞癌与单发结直肠肝转移瘤的简便评分系统。
Eur Radiol. 2023 Dec;33(12):8986-8998. doi: 10.1007/s00330-023-09873-w. Epub 2023 Jul 1.
3
Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics.

本文引用的文献

1
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.欧洲胃肠道和腹部放射学会关于肝脏磁共振成像及肝脏特异性对比剂临床应用的共识声明。
Eur Radiol. 2016 Apr;26(4):921-31. doi: 10.1007/s00330-015-3900-3. Epub 2015 Jul 21.
2
A case of a large cholangiolocellular carcinoma.一例肝内胆管细胞癌病例。
Clin J Gastroenterol. 2011 Oct;4(5):340-346. doi: 10.1007/s12328-011-0250-9. Epub 2011 Aug 7.
3
The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
基于临床影像学特征和 MRI 影像组学的肝内胆管癌 Ki67 状态联合预测模型的建立和验证。
Radiol Med. 2023 Mar;128(3):274-288. doi: 10.1007/s11547-023-01597-7. Epub 2023 Feb 11.
4
DWI Combined With Hepatobiliary-Phase Enhanced Imaging Can Better Differentiate Cholangiocarcinoma From Atypical Liver Abscesses.弥散加权成像联合肝胆期增强成像能更好地区分胆管癌与不典型肝脓肿。
Front Oncol. 2022 May 13;12:723089. doi: 10.3389/fonc.2022.723089. eCollection 2022.
5
A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma.用于术前预测肝内胆管癌微血管侵犯状态的多参数放射组学列线图
Front Oncol. 2022 Feb 24;12:838701. doi: 10.3389/fonc.2022.838701. eCollection 2022.
6
Inter-observer agreement of computed tomography and magnetic resonance imaging on gross tumor volume delineation of intrahepatic cholangiocarcinoma: an initial study.计算机断层扫描和磁共振成像在肝内胆管癌大体肿瘤体积勾画方面的观察者间一致性:一项初步研究。
Quant Imaging Med Surg. 2021 Feb;11(2):579-585. doi: 10.21037/qims-19-1093.
7
Successfully Treated Case of Cholangiolocellular Carcinoma with a Poor Hepatic Functional Reserve Reporting with Various Imaging Findings.成功治疗一例伴有多种影像学表现的低肝功能储备肝内胆小管细胞癌病例报告。
Intern Med. 2021 Mar 15;60(6):873-881. doi: 10.2169/internalmedicine.5891-20. Epub 2020 Oct 14.
8
A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma.钆塞酸二钠增强MRI的新诊断标准可能会提高肝细胞癌的诊断性能。
Liver Cancer. 2020 Aug;9(4):414-425. doi: 10.1159/000505696. Epub 2020 Apr 14.
9
Gadoxetic acid magnetic-enhanced resonance imaging in the diagnosis of cholangiocarcinoma.钆塞酸磁共振成像在胆管癌诊断中的应用。
World J Gastroenterol. 2020 Aug 7;26(29):4261-4271. doi: 10.3748/wjg.v26.i29.4261.
10
Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.混合型肝细胞癌-胆管细胞癌:2019 年世界卫生组织组织学分类系统的变化及其对基于影像的诊断的潜在影响。
Korean J Radiol. 2020 Oct;21(10):1115-1125. doi: 10.3348/kjr.2020.0091. Epub 2020 Jul 27.
结直肠癌肝转移中的靶征:磁共振成像肝胆期非典型钆塞酸二钠“摄取”
Abdom Imaging. 2015 Oct;40(7):2364-71. doi: 10.1007/s00261-015-0488-7.
4
Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging.第七届肝脏磁共振成像国际论坛共识报告
Eur Radiol. 2016 Mar;26(3):674-82. doi: 10.1007/s00330-015-3873-2. Epub 2015 Jun 13.
5
Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.局灶性结节性增生和肝细胞腺瘤:钆塞酸增强磁共振成像的准确性——系统评价。
Radiology. 2015 Nov;277(2):413-23. doi: 10.1148/radiol.2015142986. Epub 2015 May 26.
6
Intrahepatic mass-forming cholangiocarcinoma: prognostic value of preoperative gadoxetic acid-enhanced MRI.肝内肿块型胆管细胞癌:术前钆塞酸增强 MRI 的预后价值。
Eur Radiol. 2016 Feb;26(2):407-16. doi: 10.1007/s00330-015-3846-5. Epub 2015 May 23.
7
Focal liver lesions detection and characterization: The advantages of gadoxetic acid-enhanced liver MRI.局灶性肝脏病变的检测与特征分析:钆塞酸二钠增强肝脏MRI的优势
World J Hepatol. 2014 Jul 27;6(7):477-85. doi: 10.4254/wjh.v6.i7.477.
8
Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.胆管细胞癌患者根治性肝切除术后的长期生存情况。
Ann Surg Oncol. 2014 Jun;21 Suppl 3(Suppl 3):S451-8. doi: 10.1245/s10434-014-3582-0. Epub 2014 Mar 17.
9
Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.钆塞酸增强磁共振成像及扩散加权成像上的硬化型肝细胞癌:着重于肝内胆管癌的鉴别诊断
J Comput Assist Tomogr. 2013 Nov-Dec;37(6):872-81. doi: 10.1097/RCT.0b013e31829d44c1.
10
Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation.钆塞酸二钠增强 MRI 对肿块型肝内胆管细胞癌的诊断:影像学-组织学相关性研究。
AJR Am J Roentgenol. 2013 Oct;201(4):W603-11. doi: 10.2214/AJR.12.10262.